克服急性早幼粒细胞白血病及其他疾病的治疗耐药性。 - Suppr

Suppr

超能文献

Overcoming treatment resistance in acute promyelocytic leukemia and beyond.

作者信息

Fung Tsz Kan, So Chi Wai Eric

出版信息

Oncotarget. 2013 Aug;4(8):1128-9. doi: 10.18632/oncotarget.1244.

DOI:10.18632/oncotarget.1244

PMID:23934744

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3787144/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b51b/3787144/e1743b5e8dc0/oncotarget-04-1128-g001.jpg

相似文献

Overcoming treatment resistance in acute promyelocytic leukemia and beyond.

Oncotarget. 2013 Aug;4(8):1128-9. doi: 10.18632/oncotarget.1244.

Arsenic trioxide-responsive leukemia cutis in a patient with acute promyelocytic leukemia after ATRA treatment.

Leuk Lymphoma. 2006 Jul;47(7):1438-40. doi: 10.1080/10428190600612446.

Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia.

J Natl Cancer Inst. 1998 Dec 16;90(24):1906-7. doi: 10.1093/jnci/90.24.1906.

Arsenic and apoptosis in the treatment of acute promyelocytic leukemia.

J Natl Cancer Inst. 1998 Jan 21;90(2):86-8. doi: 10.1093/jnci/90.2.86.

P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As(2)O(3)), but are not the main mechanism of As(2)O(3)-resistance in acute promyelocytic leukemia cells.

Leukemia. 2003 Mar;17(3):648-50. doi: 10.1038/sj.leu.2402851.

Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia.

Curr Oncol Rep. 2000 Nov;2(6):519-23. doi: 10.1007/s11912-000-0105-x.

[Pharmacological and clinical properties of arsenic trioxide (Trisenox) for relapse or refractory acute promyelocytic leukemia therapy].

Nihon Yakurigaku Zasshi. 2005 Jun;125(6):389-96. doi: 10.1254/fpj.125.389.

Hypoxia-simulating agents selectively stimulate arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.

Haematologica. 2005 Dec;90(12):1585A.

Arsenic trioxide mechanisms of action--looking beyond acute promyelocytic leukemia.

Leuk Lymphoma. 2008 Oct;49(10):1846-51. doi: 10.1080/10428190802464745.

Treatment of acute promyelocytic leukemia with arsenic trioxide.

N Engl J Med. 1999 Apr 1;340(13):1043; author reply 1044-5. doi: 10.1056/NEJM199904013401313.

引用本文的文献

Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells.

Oncol Lett. 2018 Jan;15(1):1255-1262. doi: 10.3892/ol.2017.7353. Epub 2017 Nov 6.

HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6.

PLoS One. 2017 Jun 30;12(6):e0180142. doi: 10.1371/journal.pone.0180142. eCollection 2017.

Phenylarsine Oxide Can Induce the Arsenite-Resistance Mutant PML Protein Solubility Changes.

Int J Mol Sci. 2017 Jan 25;18(2):247. doi: 10.3390/ijms18020247.

Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.

Oncogene. 2017 Mar 30;36(13):1753-1759. doi: 10.1038/onc.2016.315. Epub 2016 Sep 5.

Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.

Cancer Cell. 2016 Jan 11;29(1):32-48. doi: 10.1016/j.ccell.2015.12.007.

Nanotechnology applications in hematological malignancies (Review).

Oncol Rep. 2015 Sep;34(3):1097-105. doi: 10.3892/or.2015.4100. Epub 2015 Jul 2.

Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.

Leukemia. 2015 May;29(5):1153-62. doi: 10.1038/leu.2014.334. Epub 2014 Dec 16.

New strategies in acute promyelocytic leukemia: moving to an entirely oral, chemotherapy-free upfront management approach.

Clin Cancer Res. 2014 Oct 1;20(19):4985-93. doi: 10.1158/1078-0432.CCR-13-2725.

Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapies.

Br J Cancer. 2015 Feb 3;112(3):413-8. doi: 10.1038/bjc.2014.374. Epub 2014 Sep 23.

DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.

Chromosoma. 2014 Dec;123(6):545-61. doi: 10.1007/s00412-014-0482-9. Epub 2014 Aug 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验